LAVA Therapeutics N.V.

Lava Therapeutics N.V. is a biotechnology company focused on leveraging its proprietary Gammabody™ platform to develop next-generation, transformative oncology drugs. The primary mission of the company is to harness the human immune system to effectively treat cancer through the development of bispecific antibodies targeting gamma delta T cells. These immune cells have the potential to recognize and destroy cancerous cells, offering innovative solutions for treating solid tumors and hematological malignancies. Lava Therapeutics operates in the highly specialized and competitive biotech sector, primarily engaging in research and development within precision medicine. The company's expertise in immuno-oncology marks it as a significant player in striving for advancements in cancer treatment. As part of the broader pharmaceutical and biotechnology industry, Lava Therapeutics contributes to the search for new therapeutic approaches, emphasizing the importance of personalized medicine in revolutionizing how cancer is treated globally.